Gene of the month: HGF

被引:57
作者
Fajardo-Puerta, Ana Belen [1 ]
Prado, Mireia Mato [2 ]
Frampton, Adam E. [1 ,2 ]
Jiao, Long R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, HPB Surg Unit, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England
关键词
HEPATOCYTE GROWTH-FACTOR; FACTOR SCATTER FACTOR; C-MET PROTOONCOGENE; EPITHELIAL MORPHOGENESIS DOWNSTREAM; RECEPTOR TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; COLORECTAL-CANCER; SIGNALING PATHWAY; EXPRESSION;
D O I
10.1136/jclinpath-2015-203575
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
Hepatocyte growth factor (HGF) is a multifunctional cytokine with important roles in cell proliferation, survival, motility and morphogenesis. Secreted by cells of mesenchymal origin, HGF is the specific ligand for the tyrosine-kinase receptor c-MET (cellular mesenchymal-epithelial transition), also called MET, which is expressed in different types of epithelial, endothelial and haematopoietic progenitor cells. The HGF/MET axis is involved in several biological processes, such as embryogenesis, organogenesis, adult tissue regeneration (including wound healing and liver regeneration) and carcinogenesis, for both solid and haematological malignancies. 1 2 HGF and its particular interaction with the MET receptor have been extensively investigated in the last decades and remain the focus of numerous clinical trials. 3-8 This short review focuses on HGF structure and function, as well as its roles in liver regeneration and different types of tumours.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 94 条
[1]
[Anonymous], 2012, Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012
[2]
Targeted treatments in colorectal cancer: state of the art and future perspectives [J].
Arnold, Dirk ;
Seufferlein, Thomas .
GUT, 2010, 59 (06) :838-858
[3]
Met endosomal signalling: In the right place, at the right time [J].
Barrow-McGee, Rachel ;
Kermorgant, Stephanie .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 49 :69-74
[4]
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway [J].
Boccaccio, C ;
Andò, M ;
Tamagnone, L ;
Bardelli, A ;
Michieli, P ;
Battistini, C ;
Comoglio, PM .
NATURE, 1998, 391 (6664) :285-288
[5]
The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms? [J].
Boissinot, Marjorie ;
Vilaine, Mathias ;
Hermouet, Sylvie .
CANCERS, 2014, 6 (03) :1631-1669
[6]
BOIX L, 1994, HEPATOLOGY, V19, P88, DOI 10.1002/hep.1840190115
[7]
IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[8]
Targeting the HGF/Met signaling pathway in cancer therapy [J].
Cecchi, Fabiola ;
Rabe, Danie C. ;
Bottaro, Donald P. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (06) :553-572
[9]
The genomic landscape of oesophagogastric junctional adenocarcinoma [J].
Chong, Irene Y. ;
Cunningham, David ;
Barber, Louise J. ;
Campbell, James ;
Chen, Lina ;
Kozarewa, Iwanka ;
Fenwick, Kerry ;
Assiotis, Ioannis ;
Guettler, Sebastian ;
Garcia-Murillas, Isaac ;
Awan, Saima ;
Lambros, Maryou ;
Starling, Naureen ;
Wotherspoon, Andrew ;
Stamp, Gordon ;
Gonzalez-de-Castro, David ;
Benson, Martin ;
Chau, Ian ;
Hulkki, Sanna ;
Nohadani, Mahrokh ;
Eltahir, Zakaria ;
Lemnrau, Alina ;
Orr, Nicholas ;
Rao, Sheela ;
Lord, Christopher J. ;
Ashworth, Alan .
JOURNAL OF PATHOLOGY, 2013, 231 (03) :301-310
[10]
Drug development of MET inhibitors: targeting oncogene addiction and expedience [J].
Comoglio, Paolo M. ;
Giordano, Silvia ;
Trusolino, Livio .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) :504-516